By Seb Joseph

GlaxoSmithKline (GSK) is reviewing its $1bn global media agency roster in an attempt to tweak its structure to the consumer health joint venture it is building with fellow drug maker Novartis.

The two companies completed the deal in March that saw both pool their consumer healthcare assets in a new business. The combined effort, is billed as the best of both companies, and GSK will review its media in order to make sure that statement rings true when it comes to advertising.

The Drum understands that Starcom, PHD and GroupM – all of which have worked with the business in the Read full story ›

Source: The Drum